The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos

Ocular Microbiology and Immunology Group
Back to OMIG Main Page

2018 OMIG Meeting Agenda

Ocular Microbiology and Immunology Group
52nd Annual Meeting
October 26, 2018
Westin Michigan Avenue Hotel

Eric G. Romanowski, MS, and Cecilia Lee, MD

Click on titles to view abstracts
6:45 a.m. Registration
7:30 a.m. Introduction by Moderators
7:35 a.m.

2017 Harry Hirsch Leiter Award Recipient:
Grace Shih, MD
Diphtheroids as a corneal pathogen in chronic ocular surface disease

7:45 a.m.

1. Evaluating the Antimicrobial Effect of Amniotic Membrane Grafts
Michele Lee, MD

7:52 a.m. 2. Is 2.5% (25mg/ml) Vancomycin the Same as 5% (50 mg/ml) in the Treatment of MRSA Keratitis?
Regis P. Kowalski
7:59 a.m.

3. Update on the Increasing Frequency of Sheen Isolates Among Pseudomonas aeruginosa Keratitis Isolates
Robert M.Q. Shanks, PhD

8:06 a.m. 4. A Multifunctional Bispecific Antibody Effective Against Pseudomonas Keratitis
Wesley Hebert, BSc
8:13 a.m. 5. Clinical Applications of Whole Metagenomic Shotgun DNA Sequencing for Diagnosis of Corneal Ulcers
Ilya M. Sluch, MD
8:20 a.m. 6. Development of a Novel Ophthalmic Antibiotic
Rachel Wozniak, MD, PhD
8:27 a.m. 7. A Contaminated Eye Care Solution Used to Prepare Corneal Donor Tissue and the Association with a Cluster of Corneal Rim Cultures Positive for Achromobacterspp
Joseph Ciolino, MD
8:34 a.m. 8. The Search For Antifungal Prophylaxis Following Artificial Cornea Surgery
Sarah Kim
8:41 a.m. 9. Optisol Supplemented with 0.255 mcg/ml Amphotericin B Does Not Eliminate Yeast at 5° C
Devin Tran, MD
8:48 a.m. 10. Understanding Fungal Virulence in Keratitis through a Reverse-Translational Approach
Kevin Fuller, MD
8:55 a.m. 11. Factors Associated with Acanthamoeba Keratitis Clearance Time
Todd Driver, MD
9:02 a.m. 12. In vitro Synergy Testing of Commonly Used Anti-amoebic Agents: Antagonism of Voriconazole
Jeremy Keenan, MD
9:09 a.m. 13. Resolution of Recurrent Acanthamoeba keratitis with Oral Miltefosine
Nikhil Dewan, MD
9:16 a.m. BREAK
9:35 a.m 14. Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) as Adjunct Treatment for Infectious Keratitis
Jaime Martinez, MD
9:42 a.m. 15. Treatment of Corneal Ulcers with a Novel Far-UV SterilrayTM Wavelength (222nm) Lamp
J. James Rowsey, MD
9:49 a.m. 16. Impact of PDAT on S. aureus Inflammatory Response in an EpiCorneal Model
Alejandro Arboleda, MD
9:56 a.m. 17. Cellular and Molecular Assessment of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) on Corneal Endothelium and Limbal Stem Cell Niche
Andrea Naranjo, MD
10:03 a.m. 18. Alpha-MSH Pretreatment Attenuates Corneal Endothelium Morphometric Changes in Eye Bank Stored Corneas in the Presence of Acute Oxidative Stress
Zala Luznik, MD, PhD
10:10 a.m. 19. Toxic Posterior Segment Syndrome following Dropless Cataract Surgery
Nikitha Reddy, MD
10:17 a.m. 20. Long-term Outcome of Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) for Delivery of Bevacizumab in the Treatment of Corneal Neovascularization
Jia Yin, MD, PhD
10:24 a.m. 21. Long-term Antimicrobial Silk-based Drug Delivery Implant for the Posterior Segment
Irmgard Behlau, MD
10:31 a.m. 22. Five-year Trends in Adenoviral Conjunctivitis in Employees of One Medical Center
Irene Kuo, MD
10:38 a.m.

23. Concomitant Herpetic Keratitis and Acute Retina Necrosis
Wendy Ming, MD

10:45 a.m. 24. Comparison of Post-Herpetic and Post-Refractive Surgery-Related Corneal Neuralgia
Mehmet Cuneyt Ozman, MD
10:52 a.m. 25. Associations Between Meibum Quality and Sphingolipid Quantity and Composition
Vikram Paranjpe, BS
10:59 a.m. 26. Dynamic Assessment of the Tear Film Muco-Aqueous and Lipid Layers Using a Novel Tear Film Imager (TFI)
Anat Galor, MD, MSPH
11:06 a.m. 27. Botulinum toxin A Improves Photophobia and Sensations of Dryness Independent of Ocular Surface Parameters
Jodi Hwang, BS
11:13 a.m. 28. Safety and Effiacy of Chronic Loteprednol Etabonate Gel Use for Dry Eye Disease
Neslihan Dilruba Koseoglu, MD
11:20 a.m. BREAK
11:30 a.m. Thygeson Lecture: Strategies to Induce Immune Tolerance for High Risk Corneal Transplants

Victor L. Perez, MD

Professor of Ophthalmology
Duke University School of Medicine, and
Director, Duke Eye Center for Ocular Immunology
12:15 p.m. Closing Comments and Awards
12:45 p.m.

Business Luncheon -- Marquette Room

Top of Page